New Zealand Children’s Nutrition Brand Zeacura Enters the Chinese Market

Greenfield Joins Hands with Xiuzheng Pharmaceutical Group; the First Five New Products Are All Manufactured in New Zealand.

[October XX, 2026, Simultaneous Release in New Zealand and China] Zeacura, a children’s‑nutrition brand originating from New Zealand, has officially entered the Chinese mainland market. Founded and owned by New Zealand nutrition enterprise Greenfield (Greenfield Nutrition NZ Limited), Zeacura is brought to China through a partnership between Greenfield and Xiuzheng Pharmaceutical Group, with five new children‑nutrition products launched concurrently. All products released for the Chinese market are developed and manufactured in New Zealand. Among them, Zeacura Soothe‑Sensitive Probiotics and Zeacura Gut‑Care Probiotics are already available for sale locally in New Zealand.

Zeacura is a children‑nutrition brand under Greenfield. Headquartered in Auckland, New Zealand, Greenfield holds the brand rights to Zeacura, which focuses on children’s nutrition. As a New Zealand‑based enterprise specialising in nutritional science, Greenfield leverages local natural ecosystems and research‑driven supply chains. It consistently selects high‑quality raw materials globally and builds a nutrition‑product system catering to diverse consumer groups. For quality control, the enterprise implements national‑level batch‑by‑batch testing. Committed to integrity‑driven business operations, it pursues long‑term growth underpinned by rigorous quality standards. Greenfield’s official website: http://www.greenfieldnutrition.co.nz/.

Zeacura’s premium quality is backed by Greenfield’s strict quality and regulatory frameworks in New Zealand. As a New Zealand‑based nutrition manufacturer, Greenfield falls under direct oversight via the Risk Management Programme (RMP) administered by the Ministry for Primary Industries (MPI) of New Zealand. It has obtained international third‑party certifications for GMP and HACCP issued by SGS. Notably, Greenfield has advanced continuously to Ceiling Step 5, the highest achievable tier, under MPI’s Performance‑Based Verification (PBV) scheme, and has passed unannounced surprise verifications with perfect results. Furthermore, Greenfield is listed on MPI’s China‑export eligible enterprise register, holding compliant qualifications for exporting goods to China. Introducing Zeacura to China marks a key milestone in its global expansion, bringing New Zealand’s stringent food‑safety regulatory standards and pure nutritional offerings to Chinese families.

Xiuzheng Pharmaceutical Group was listed among China’s Top 500 Private Enterprises in 2025 (released by the All‑China Federation of Industry and Commerce). Having long‑term engagement in the maternal‑infant and children‑health sector, its established channel resources and market expertise will support Zeacura’s market roll‑out across China.

Melissa Li, Founder and Chief Executive Officer of Greenfield, commented: “The Chinese market constitutes a vital component of Greenfield’s global footprint. As a New Zealand‑origin children‑nutrition brand, Zeacura enables us to bring New Zealand’s children‑nutrition concepts and products to China. Together with Xiuzheng Pharmaceutical Group, we aim to deliver expanded nutritional options for Chinese families.”

Lin Qiang, relevant representative from Xiuzheng Pharmaceutical Group, stated: “Xiuzheng Pharmaceutical Group has long focused on children and infant health. Through this partnership with Greenfield, we intend to combine accumulated strengths in research & development, manufacturing and distribution, to bring Zeacura and its New Zealand‑made children‑nutrition products to Chinese consumers.”

Zeacura has undergone extensive R&D iterations with multiple rounds of adjustments to formulations and compliance standards. In 2026, Zeacura unveiled its Chinese‑market brand proposition: Pure Nutrition, Natural Care.

The name Zeacura embodies the ethos of natural protection. “ZEA” draws its meaning from the gifts of native land, representing New Zealand’s natural and pure bounty; “CURA” (/ˈkjʊərə/) derives from Latin, signifying care and nurturing.

Rooted in Purity forms Zeacura’s foundational principle. New Zealand’s pristine natural environment and high‑standard manufacturing systems constitute Zeacura’s origin and core strength.

Nutritional Authenticity represents its quality guideline. It adheres to science‑backed formulations and strict quality controls, avoids over‑hyped marketing claims, and supports children’s growth via evidence‑based approaches.

Natural Protection stands as its long‑term commitment. It respects children’s natural growth rhythms, offering steady, long‑term companionship without undue haste.

All five newly‑launched Zeacura children‑nutrition products entering the Chinese market are manufactured in New Zealand. Centred on the brand promise “Pure Nutrition, Natural Care”, they address gut maintenance, sensitivity management, immune support and daily dietary‑supplement requirements.

■ Zeacura Soothe‑Sensitive Probiotics, manufactured in New Zealand. Formulated with a scientifically balanced blend of five functional strains, featuring core combinations of Bb‑12 and Lactobacillus rhamnosus LGG. It delivers 20 billion high‑activity viable bacteria. Subjected to multiple production‑quality and safety inspections, it delivers daily gut‑nutritional support for children prone to sensitivities.

■ Zeacura Gut‑Care Probiotics, manufactured in New Zealand. It adopts four premium synergistic strains with core strains NCFM and Bi‑07, helping modulate intestinal microecology and preserve digestive‑barrier function.

■ Zeacura Day‑Night Dual‑pack Probiotics, made in New Zealand with a day‑night‑phased formulation. The daytime formula incorporates PS paired with strain P8; the night‑time formula combines Weissella confusa BC99, casein hydrolysate and L‑theanine, tailored to children’s nutritional needs in daytime and night‑time scenarios.

■ Zeacura IDP Lactoferrin, manufactured in New Zealand. Centred on lactoferrin, it is compounded with two key active ingredients EpiCor and HMO, supplying daily protective nutritional support for children’s development.

■ Zeacura Kiwi Fruit Powder, produced in New Zealand. Featuring core actives EpiCor and yeast β‑glucan, it is blended with natural vitamin‑C sources including acerola‑cherry powder, kiwi‑fruit powder and maqui‑berry powder to supplement children’s everyday dietary nutrition.

The simultaneous roll‑out of these five products forms Zeacura’s initial product portfolio for China. By combining New Zealand‑based manufacturing capabilities and Greenfield’s global R&D reserves, Zeacura will leverage Xiuzheng Pharmaceutical Group’s domestic expertise and channel resources within the children‑health sector to deliver products aligned with Chinese children’s nutritional requirements. Going forward, Greenfield and Xiuzheng Pharmaceutical Group will further introduce new products and develop channel partnerships according to Chinese‑market feedback, continuously enriching Zeacura’s product offerings for children’s nutrition in China.